The changing burden of disease in Türkiye, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023


Birinci Ş., Bora Başara B., Aktaş M., Kervan Ü., Abdulsater B., Ağagündüz D., ...Daha Fazla

THE LANCET GLOBAL HEALTH, ss.1-12, 2026 (SCI-Expanded, SSCI, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2026
  • Dergi Adı: THE LANCET GLOBAL HEALTH
  • Derginin Tarandığı İndeksler: Scopus, Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Chemical Abstracts Core, EMBASE, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.1-12
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: Türkiye has had improvements in population health over the past three decades, driven by the Health Transformation Programme launched in 2003, which expanded primary care through the family medicine system and, through the General Health Insurance Scheme, extended population coverage to near-universal levels. However, recent shocks, including the COVID-19 pandemic and the catastrophic February 2023 earthquakes, have caused temporary reverses in health gains.

Methods: We used Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 estimates for Türkiye, produced using the standard GBD methods applied to all 204 countries and territories, to describe age-standardised trends from 1990 to 2023 in life expectancy, healthy life expectancy (HALE), mortality, years of life lost, years lived with disability, disability-adjusted life-years (DALYs), and risk-attributable burden, by sex, age, and cause. Estimates are reported as means of 250 draws with 95% uncertainty intervals (UIs). The effects of the COVID-19 pandemic and of the February 2023 earthquakes are described by examining the annual series across 2019–23 and, for the earthquakes, the burden assigned to the GBD cause exposure to forces of nature in 2023.

Findings: Between 1990 and 2023, Türkiye’s life expectancy increased from 68·1 years to 76·1 years (male: 65·2 years to 73·9 years; female: 71·2 years to 78·3 years), and HALE from 58·7 years to 65·1 years. The COVID-19 pandemic caused a 2·0-year decline in life expectancy, whereas the 2023 Kahramanmaraş earthquakes resulted in over 53 000 deaths. Age-standardised all-cause mortality declined by 34·9% from 1040·3 (95% UI 1022·4–1061·6) per 100 000 in 1990 to 677·3 (634·3–731·6) in 2023, with reductions of 36·5% in non-communicable diseases (NCDs) from 836·5 (808·4–861·7) in 1990 to 530·8 (488·4–580·8), 64·6% in communicable, maternal, neonatal, and nutritional diseases from 151·5 (135·5–167·0) in 1990 to 53·7 (43·5–63·9), but an increase of 77·5% in injuries from 52·3 (41·1–64·8) in 1990 to 92·8 (85·8–100·8) in 2023 due to the earthquakes. The top three causes of mortality in 2023 were ischaemic heart disease with an age-standardised mortality rate of 123·7 per 100 000 (95% UI 99·7–150·5), exposure to forces of nature (the February 2023 earthquakes) 65·2 (59·3–71·6), and stroke 57·0 (43·4–71·4). The leading age-standardised risk factors contributing to deaths in 2023 were high blood pressure with a rate of 137·4 per 100 000 (104·0–173·9), high BMI (86·9 [45·3–125·6]), and high fasting plasma glucose (85·8 [74·0–100·6]). Although our findings show a reduction in smoking-attributable burden, smoking remains the leading DALYs age-standardised risk factor for men in 2023 at 3928 per 100 000 (3098–4669). Among women, high BMI emerged as the leading risk factor of age-standardised DALYs at 2548 per 100 000 (1141–3719). Diabetes rose to become the third leading cause of health loss in 2023, and metabolic risks (ie, high BMI, high blood pressure, and high fasting plasma glucose) were the three leading risk factors for DALYs in 2023.

Interpretation: Türkiye has achieved sustained health gains but faces rising NCDs, dietary, and behavioural risks that need to be monitored and addressed through multisectoral efforts. Strengthening prevention and early detection while leveraging digital health infrastructure is essential for Türkiye to build a strong health system.

Funding: Gates Foundation.